WhiteSwell
WhiteSwell is dedicated to advancing treatment of acute decompensated heart failure .
Operating in biotechnology, health care based in European Union (EU), Europe, Middle East, and Africa (EMEA), WhiteSwell was founded in 2014.
The company sits in the biotechnology, health care segment, where it competes on its core product or service.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
The company is listed at the Series_B stage of development.
Its team size is recorded as c_00011_00050 employees.
It has disclosed roughly $30M in funding.
| Sector | Biotechnology, Health Care |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Country | IE |
| Founded | 2014 |
| Employees | c_00011_00050 |
| Stage | series_b |
| Total funding | $30,000,000 |
Website: whiteswell.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account